Amalgam Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
58
- Latest Deal Type
-
Debt Refin.
- Latest Deal Amount
-
$20M
- Investors
-
6
Amalgam General Information
Description
Operator of a digital healthcare platform intended to improve clinical and behavioral outcomes for chronic disease management. The company's platform provides a variety of features, such as data insights, clinical decision support tools, and patient engagement tools, enabling healthcare providers to improve patient care and reduce costs.
Contact Information
Website
www.amalgamrx.comCorporate Office
- 1007 North Orange Street
- Suite 400
- Wilmington, DE 19803
- United States
Corporate Office
- 1007 North Orange Street
- Suite 400
- Wilmington, DE 19803
- United States
Amalgam Timeline
Amalgam Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Debt Refinancing | 12-Aug-2025 | $20M | Completed | Generating Revenue | ||
| 8. Debt - General | Completed | Generating Revenue | ||||
| 7. Later Stage VC | 31-Jan-2024 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 01-Nov-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 03-Jan-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 20-Jan-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 10-Feb-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 02-May-2019 | $1.22M | $1.44M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 24-Mar-2016 | $215K | $215K | Completed | Generating Revenue |
Amalgam Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B | ||||||||
| Series A-2 | 595,238 | $0.000100 | $0.2 | $3.36 | $3.36 | 1x | $3.36 | 8.88% |
| Series A | 50,000 | $0.000100 | $0.6 | $10 | $10 | 1x | $1 | 7.46% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Amalgam Comparisons
Industry
Financing
Details
Amalgam Competitors (4)
One of Amalgam’s 4 competitors is RightPatient, a Corporation company based in Atlanta, GA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| RightPatient | Corporation | Atlanta, GA | ||||
| Click Therapeutics | Venture Capital-Backed | New York, NY | ||||
| Verato | Venture Capital-Backed | McLean, VA | ||||
| Akili (IT Consulting and Outsourcing) | Corporation | Irving, TX |
Amalgam Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Amalgam Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Amalgam Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Catalio Capital Management | Venture Capital | Minority | ||
| CVS Health Ventures | Corporate Venture Capital | Minority | ||
| Novo Nordisk | Corporation | Minority | ||
| Plug and Play | Accelerator/Incubator | Minority | ||
| Supermorpheous | Venture Capital | Minority |
Amalgam Investments & Acquisitions (2)
Amalgam’s most recent deal was a Corporate Asset Purchase with Geetha (Adaptive, Conversational and Artificial Intelligence Assets). The deal was made on 20-May-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Geetha (Adaptive, Conversational and Artificial Intelligence Assets) | 20-May-2021 | Corporate Asset Purchase | Buildings and Property | ||
| Avhana Health | 13-Jan-2021 | Merger/Acquisition | Decision/Risk Analysis |
Amalgam FAQs
-
When was Amalgam founded?
Amalgam was founded in 2016.
-
Where is Amalgam headquartered?
Amalgam is headquartered in Wilmington, DE.
-
What is the size of Amalgam?
Amalgam has 58 total employees.
-
What industry is Amalgam in?
Amalgam’s primary industry is Enterprise Systems (Healthcare).
-
Is Amalgam a private or public company?
Amalgam is a Private company.
-
What is Amalgam’s current revenue?
The current revenue for Amalgam is .
-
How much funding has Amalgam raised over time?
Amalgam has raised $39.6M.
-
Who are Amalgam’s investors?
Catalio Capital Management, CVS Health Ventures, Novo Nordisk, Plug and Play, and Supermorpheous are 5 of 6 investors who have invested in Amalgam.
-
Who are Amalgam’s competitors?
RightPatient, Click Therapeutics, Verato, and Akili (IT Consulting and Outsourcing) are competitors of Amalgam.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
